Xu R - Search Results

1

Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.

Lu T, Xu R, Wang CH, Zhao JY, Peng B, Wang J, Zhang LY. Lu T, et al. Among authors: xu r. Front Genet. 2022 Jun 6;13:853113. doi: 10.3389/fgene.2022.853113. eCollection 2022. Front Genet. 2022. PMID: 35734437 Free PMC article.

2

Ischemia induces endoplasmic reticulum stress and cell apoptosis in human brain.

Duan SR, Wang JX, Wang J, Xu R, Zhao JK, Wang DS. Duan SR, et al. Among authors: xu r. Neurosci Lett. 2010 May 21;475(3):132-5. doi: 10.1016/j.neulet.2010.03.058. Epub 2010 Mar 27. Neurosci Lett. 2010. PMID: 20347937

3

A novel protein ubiquitination-related five-gene signature predicts overall survival in patients with lung adenocarcinoma.

Xu R, Lu T, Wang J, Zhang L. Xu R, et al. Aging (Albany NY). 2021 Mar 10;13(6):8510-8523. doi: 10.18632/aging.202663. Epub 2021 Mar 10. Aging (Albany NY). 2021. PMID: 33714206 Free PMC article.

4

Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma.

Lu T, Xu R, Li Q, Zhao JY, Peng B, Zhang H, Guo JD, Zhang SQ, Li HW, Wang J, Zhang LY. Lu T, et al. Among authors: xu r. Mol Ther Oncolytics. 2021 Feb 20;21:134-143. doi: 10.1016/j.omto.2021.02.011. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 33981829 Free PMC article.

5

Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinoma.

Xu R, Lu T, Zhao J, Li Q, Wang J, Peng B, Liu J, Zhang P, Qu L, Chang X, Yao L, Zhang L. Xu R, et al. Ann Transl Med. 2021 Nov;9(22):1692. doi: 10.21037/atm-21-5645. Ann Transl Med. 2021. PMID: 34988201 Free PMC article.

6

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development.

Xu R, Lu T, Zhao J, Wang J, Peng B, Zhang L. Xu R, et al. Front Cell Dev Biol. 2022 Feb 21;10:815596. doi: 10.3389/fcell.2022.815596. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35265614 Free PMC article.

7

The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery.

Wang J, Li H, Xu R, Lu T, Zhao J, Zhang P, Qu L, Zhang S, Guo J, Zhang L. Wang J, et al. Among authors: xu r. BMC Pulm Med. 2022 Mar 25;22(1):104. doi: 10.1186/s12890-022-01901-7. BMC Pulm Med. 2022. PMID: 35337299 Free PMC article.

8

Mitochondrial Homeostasis-Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma.

Peng B, Lou H, Chen C, Wang L, Li H, Lu T, Na R, Xu R, Xin T, Yao L, Xu H, Wang K, Liu X, Zhang L. Peng B, et al. Among authors: xu r, xu h. Front Genet. 2022 Jun 13;13:870302. doi: 10.3389/fgene.2022.870302. eCollection 2022. Front Genet. 2022. PMID: 35769997 Free PMC article.

9

A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments.

Wang C, Lu T, Xu R, Chang X, Luo S, Peng B, Wang J, Yao L, Wang K, Shen Z, Zhao J, Zhang L. Wang C, et al. Among authors: xu r. J Thorac Dis. 2022 Jun;14(6):2131-2146. doi: 10.21037/jtd-22-494. J Thorac Dis. 2022. PMID: 35813746 Free PMC article.

10

Identification of lactate metabolism-related subtypes and development of a lactate-related prognostic indicator of lung adenocarcinoma.

Chang X, Lu T, Xu R, Wang C, Zhao J, Zhang L. Chang X, et al. Among authors: xu r. Front Genet. 2022 Aug 24;13:949310. doi: 10.3389/fgene.2022.949310. eCollection 2022. Front Genet. 2022. PMID: 36092870 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,201 results

Search Page

Filters